Skip to main content

Table 2 Univariate analysis of disease specific survival and overall survival

From: Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers

Variables

Ā Ā 

Disease-specific survival

Overall survival

Ā Ā 

N

HR

95% CI

p

HR

95% CI

p

Age (yrs)

Ā Ā Ā Ā Ā Ā Ā Ā 
Ā 

ā‰¤ 65

35

1

Ā Ā 

1

Ā Ā 
Ā 

> 65

107

1.88

0.69ā€“5.08

0.21

2.03

0.78ā€“5.25

0.15

Sex

Ā Ā Ā Ā Ā Ā Ā Ā 
Ā 

Male

115

1

Ā Ā 

1

Ā Ā 
Ā 

Female

27

1.45

0.47ā€“4.46

0.52

1.3

0.44ā€“3.86

0.63

Tumor grade

Ā Ā Ā Ā Ā Ā Ā Ā 
Ā 

Low

11

1

Ā Ā 

1

Ā Ā 
Ā 

High

131

2.97

0.42ā€“20.90

0.27

2.99

0.46ā€“19.58

0.25

Stage

Ā Ā Ā Ā Ā Ā Ā Ā 
Ā 

NMIBC

82

1

Ā Ā 

1

Ā Ā 
Ā 

MIBC

60

11.78

4.71ā€“29.43

<0.0001

8.83

3.65ā€“21.32

0.0015

Combined immunostaining score for CXCL1

Ā Ā Ā Ā Ā Ā Ā Ā 
Ā 

None / Low

34

1

Ā Ā 

1

Ā Ā 
Ā 

Moderate

53

3.45

0.84ā€“14.13

0.085

2.68

0.76ā€“9.50

0.13

Ā 

High

55

5.73

1.92ā€“17.10

0.0018

4.63

1.60ā€“13.37

0.0047

  1. Abbreviations: HRā€‰Hazard ratio, 95% CIā€‰95% confidence interval, NMIBCā€‰Non-muscle invasive bladder cancer, MIBCā€‰Muscle invasive bladder cancer.